|
Volumn 4, Issue 2, 1999, Pages 67-71
|
Lymphocyte transformation test for the evaluation of adverse effects of antituberculous drugs.
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFECTIVE AGENT;
BROXURIDINE;
ISONIAZID;
RIFAMPICIN;
TUBERCULOSTATIC AGENT;
ADULT;
ANAPHYLAXIS;
ARTICLE;
ATYPICAL MYCOBACTERIOSIS;
CASE REPORT;
CELL CULTURE;
CELLULAR IMMUNITY;
CHEMICALLY INDUCED DISORDER;
COMPARATIVE STUDY;
DNA REPLICATION;
DRUG COMBINATION;
DRUG EFFECT;
DRUG ERUPTION;
DRUG HYPERSENSITIVITY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FEMALE;
HUMAN;
IMMUNOLOGY;
KIDNEY DISEASE;
LYMPHOCYTE ACTIVATION;
MALE;
MIDDLE AGED;
MONONUCLEAR CELL;
MYCOBACTERIOSIS;
MYCOBACTERIUM KANSASII;
NEUROLOGIC DISEASE;
TOXIC HEPATITIS;
TUBERCULOSIS;
ADULT;
ANAPHYLAXIS;
ANTI-BACTERIAL AGENTS;
ANTITUBERCULAR AGENTS;
BROMODEOXYURIDINE;
CELLS, CULTURED;
DNA REPLICATION;
DRUG ERUPTIONS;
DRUG HYPERSENSITIVITY;
DRUG THERAPY, COMBINATION;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FEMALE;
HEPATITIS, TOXIC;
HUMANS;
IMMUNITY, CELLULAR;
ISONIAZID;
KIDNEY DISEASES;
LEUKOCYTES, MONONUCLEAR;
LYMPHOCYTE ACTIVATION;
MALE;
MIDDLE AGED;
MYCOBACTERIUM INFECTIONS;
MYCOBACTERIUM INFECTIONS, ATYPICAL;
MYCOBACTERIUM KANSASII;
NERVOUS SYSTEM DISEASES;
RIFAMPIN;
TUBERCULOSIS;
|
EID: 0033601902
PISSN: 09492321
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (28)
|
References (0)
|